TY  - GEN
AU  - Liang,Jin-Hua
AU  - Wang,Li
AU  - Zhu,Hua-Yuan
AU  - Qian,Jun
AU  - Liao,Hui
AU  - Wu,Jia-Zhu
AU  - Xia,Yi
AU  - Wu,Wei
AU  - Cao,Lei
AU  - Fan,Lei
AU  - Li,Jian-Yong
AU  - Xu,Wei
TI  - Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial
SN  - 1592-8721
PY  - 2021///0427
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Etoposide
KW  - Humans
KW  - Lymphohistiocytosis, Hemophagocytic
KW  - diagnosis
KW  - Lymphoma, Non-Hodgkin
KW  - complications
KW  - Prednisone
KW  - Vincristine
N1  - Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2019.220301
ER  -